柏垠生物重组贻贝粘蛋白绿色生物制造：突破产业瓶颈，引领生物材料绿色革新

Core Insights - The company, Baiyin Biotechnology, focuses on the development of innovative biomaterials, leveraging high-throughput synthetic biology and artificial intelligence to create sustainable and low-cost solutions in the biomaterials sector [1] Group 1: Company Overview - Baiyin Biotechnology has successfully launched several core products, including recombinant mussel adhesive protein, Colamin sodium alginate, and fibronectin, gaining recognition from multiple Fortune 500 companies [1] - The company has completed nearly 300 million yuan in financing, with investments from notable institutions such as Wu Bo Lian Guang Pharmaceutical Fund and Wuyuan Capital, providing solid support for technological research and industrialization [1] Group 2: Product Innovation - The recombinant mussel adhesive protein, known as "marine soft gold," has significant value in wound care and medical aesthetics, but traditional production methods face challenges such as low yield and high resource consumption [2] - Baiyin Biotechnology has developed a green biomanufacturing system for recombinant mussel adhesive protein using synthetic biology, achieving the highest yield strains globally, which can replace billions of mussels in extraction [2] - The company has addressed application challenges such as compatibility and discoloration, creating multi-scenario solutions and establishing a robust intellectual property system to ensure product safety and stability [2] Group 3: Industry Impact - The project has established Baiyin Biotechnology as the first company in China to complete the medical device raw material filing for recombinant mussel adhesive protein and to lead the formulation of the first related group standard, filling a gap in the industry [2] - By March 2025, the company is expected to receive multiple medical device product registrations centered on recombinant mussel adhesive protein, launching a comprehensive series of products for wound care and mucosal repair [2] - The project transforms the traditional model reliant on natural resource extraction, setting a benchmark for "green alternatives to traditional methods," significantly reducing production costs and promoting the accessibility of high-performance biomaterials [2][3]